Picking the Lock with a Hairpin Did HIV-1 Learn the Art from Chemokines? by Lusso, Paolo
Structure, Vol. 11, 129–132, February, 2003, 2003 Elsevier Science Ltd. All rights reserved. PII S0969-2126(03)00013-3
Previews
references therein), but the results have been inconsis-Picking the Lock with a Hairpin:
tent, presumably because of the inherent conforma-Did HIV-1 Learn the Art tional flexibility of the V3 domain, in addition to the disor-
dered nature of isolated peptides outside the contextfrom Chemokines?
of the native protein. What makes the present study
particularly intriguing is that the authors went on to
search a protein database for homology with their two
The remarkable parallel homology identified between V3 structures, identifying a remarkable structural and
two alternative conformations of the V3 loop of HIV-1 sequence similarity with  hairpins in the physiological
and  hairpins in CCR5- and CXCR4-specific chemo- ligands of the HIV coreceptors, namely, chemokines.
kines suggests a potential structural basis for the co- The 447-52D-bound V3 conformation showed a close
receptor selectivity of different HIV-1 variants. correspondence with the  hairpin formed by the 2 and
3 strands of two CCR5-specific chemokines, RANTES
The art of unlocking receptor gateways on the cellular and MIP-1, as well as those of vMIP-II, a CCR5 binding
surface is an essential tool in the survival kit of obligate chemokine homolog encoded by human herpesvirus 8;
intracellular parasites, like viruses. A dramatic accelera- conversely, the 0.5-bound structure was found to
tion in our understanding of the mechanism of entry of mimic the  hairpin of SDF-1, the only known natural
primate immunodeficiency viruses into host cells was ligand of CXCR4. Thus, the different  hairpin conforma-
ignited by a cluster of complementary discoveries made tions adopted by the V3 loop might represent the spe-
between 1995 and 1996: first, with the recognition that cific molecular keys used by HIV-1 to express its core-
certain chemokines, such as RANTES, MIP-1, and ceptor preference.
MIP-1, act as specific natural inhibitors of human im- Unfortunately, when the structure of gp120 was
munodeficiency virus (HIV) infection [1] and second, a solved, crystals could only be obtained after truncation
few months later, with the identification of two heptaheli- of several domains, including the V1/V2 and V3 loops
cal chemokine receptors, CXCR4 and CCR5, as critical [3]; therefore, no structural information on the V3 loop
coreceptors for HIV entry, in conjunction with the “clas- within the context of the native gp120 protein has been
sic” CD4 receptor (reviewed in [2]). The differential use provided. The V3 loop has long been considered as a
of such coreceptors, which underlies the biological di- critical determinant of the viral coreceptor choice, as
versity among HIV-1 strains, may have important clinical formally demonstrated by domain-swapping studies
relevance, since CCR5-dependent variants are preferen- with biologically diverse HIV-1 molecular clones [8, 9],
tially transmitted in vivo and predominate in asymptomatic although the contiguous V1/V2 region may also exert
patients, whereas the emergence of CXCR4-using vari- a significant influence [10]. Moreover, multiple lines of
ants is commonly associated with the progression to evidence suggest that the V3 makes direct contact with
full-blown disease [2]. Despite these rapid advance- the coreceptor during the infectious process (see refer-
ments and the extraordinary wealth of information pro- ences in [4, 6, 7]). Yet the coreceptor binding surface
vided two years later by the high-resolution structure of of gp120 is not limited to the V3 loop. Several amino
a deglycosylated core of the external HIV-1 envelope acid residues predicted by mutagenesis to interact with
glycoprotein gp120 in complex with the CD4 receptor the coreceptor were mapped to the bridging sheet [11],
and a human antibody [3], the structural basis for core- an antiparallel, four-stranded  sheet that interconnects
ceptor recognition and selectivity has remained largely the inner and outer domains of gp120 and that is unrav-
undefined. eled and/or stabilized upon CD4 binding [3]. However,
In this issue of Structure, Sharon et al. [4] propose a unlike the V3 loop, the bridging sheet is believed to
tantalizing new model that may account for the corecep- primarily contribute “common” determinants for core-
tor selectivity of the different biological variants of HIV-1. ceptor recognition, as suggested by a high degree of
They determined the solution structure of a synthetic sequence conservation among all primate immunodefi-
peptide derived from the third variable (V3) domain of ciency viruses and by the marked structural homology
gp120, a 34–37 aa disulfide-bonded loop that consti- documented between gp120 core molecules with differ-
tutes one of the major targets of virus-neutralizing anti- ent coreceptor specificity [3, 12].
bodies [5], in complex with a human antibody fragment Although the finding of a parallel structural homology
(447-52D Fv), showing that the antibody contact inter- between alternative V3 loop conformations and core-
face adopts a  hairpin conformation, consisting of two ceptor-specific chemokines is remarkable, the model is
antiparallel  strands (residues R313–I316 and A323– still essentially theoretical, and some important ques-
T326) linked by an inverse  turn (corresponding to the tions remain to be answered. The first regards the recep-
highly conserved GPG motif at the tip of the V3 loop). tor contact surface of chemokines. In fact, both in
A distinct  hairpin conformation was previously re- RANTES and in SDF-1, the V3-homologous  hairpin
ported by the same group for another V3-derived pep- does not appear to be directly implicated in the interac-
tide in complex with a murine antibody fragment (0.5 tion with the receptor, which was shown to involve pri-
Fv) [6]. Numerous structures of V3-derived synthetic marily two other sites, the N loop and the N-terminal
region [13–15]. Likewise, on the V3 loop side, one of thepeptides have been reported in the past ([7] and the
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two residues that were previously identified as most Paolo Lusso
critical for coreceptor selectivity, i.e., position 329 [16], Unit of Human Virology
is located outside the  hairpin structure. It is plausible, Deptartment of Biological and Technological
as the authors discuss, that the charge of the neigh- Research (DIBIT)
boring residues can influence the structure of the  San Raffaele Scientific Institute
hairpin, favoring the adoption of a specific conformation, 20132 Milan
but this hypothesis needs to be validated. Another chal- Italy
lenging point for the proposed model is the fact that,
despite their dual conformation associated with a differ-
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